LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

MP82-19 ENDOSCOPIC MANAGEMENT OF UPPER TRACT UROTHELIAL CANCER - KIDNEY SPARING AT WHAT COST?

Photo from academic.microsoft.com

respectively). Furthermore, in male patients, the 5-year UTUC recurrence rate was significantly lower in patients treated with BCG (2.0%) than in those without BCG (4.3%, p[0.022), whereas no significant differences… Click to show full abstract

respectively). Furthermore, in male patients, the 5-year UTUC recurrence rate was significantly lower in patients treated with BCG (2.0%) than in those without BCG (4.3%, p[0.022), whereas no significant differences were observed in female patients. In subgroups of older male patients ( 70 years), the 5-year UTUC recurrence rate was significantly lower in patients treated with BCG (1.6%) than in those without BCG (5.9%, p[0.031). In subgroups of younger male patients (<70 years), no significant differences were noted between these two groups. CONCLUSIONS: Intravesical BCG instillation after TURBT may prevent UTUC as well as bladder recurrence, particularly in older male NMIBC patients.

Keywords: mp82 endoscopic; endoscopic management; upper tract; tract urothelial; management upper; male patients

Journal Title: Journal of Urology
Year Published: 2020

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.